Asia Pacific remains a key growth market for in vitro diagnostics, with the regional IVD market estimated at USD 27.01 billion in 2026 and projected to reach USD 35.4 billion by 2031, growing at a 5.54% CAGR. Rising healthcare investment, broader diagnostic access, and an increasing chronic disease burden continue to support steady demand across the region.
Precision Diagnostics and Decentralized Testing Gain Momentum
Disposable diagnostic devices are expected to grow faster than the overall market as microfluidic cartridge technologies bring lab-grade molecular and immunoassay testing closer to patients. These single-use solutions support point-of-care and self-testing models by reducing maintenance needs and improving biosafety, particularly for infectious disease screening.
At the same time, oncology diagnostics are emerging as the fastest-growing application segment. Advances in liquid biopsy, genomic panels, and AI-supported analysis are enabling earlier detection and more personalized treatment decisions, accelerating the adoption of precision medicine across Asia Pacific.
What This Means for Manufacturers
For manufacturers, this growth comes with increasing expectations around regulatory readiness, product classification, and market-specific compliance. Faster innovation cycles, expanded point-of-care use, and the shift toward precision diagnostics require careful planning to avoid delays and ensure smooth market entry across multiple Asia Pacific markets.
At Andaman Medical, we support MedTech and IVD manufacturers by translating these trends into clear regulatory and market access strategies. From early-stage planning and registration to ongoing compliance and post-market support, our teams help manufacturers navigate the region’s diverse regulatory requirements with confidence.
Contact us to learn how regulatory requirements, market-specific capabilities, and evolving healthcare priorities across Southeast Asia may impact your product development, validation strategy, and market entry timelines.
Source: https://www.mordorintelligence.com/industry-reports/asia-pacific-in-vitro-diagnostics-market